Loading, please wait ...

News Analytics

image jpg?width=2000&height=2000.
MONDAY, June 27, 2022 (HealthDay News) -- Paxlovid appears to living up to its reputation as the Tamiflu treatment for COVID-19, maintaining its effectiveness even against emerging variants, a new study shows. The antiviral COVID pill reduced the risk of hospitalization by 45% when administered to people infected by the coronavirus, researchers report.

The Angle

Subject Matter

  • Healthcare 100.00%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction






Depth Chart

Here we provide depth for the multitude of dimensions lacing this article.

Connect your favorite information below with the lead sentence at the top of the page to build a mental model of the story.